Related Experiment Video
Updated: May 12, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Ischaemic heart disease in the ageing woman
Sofia A Papadopoulou1, Juan Carlos Kaski
1Cardiovascular Sciences Research Centre, St George's University of London, Cranmer Terrace, London SW17 0RE, UK.
Insights
Women face higher cardiovascular disease mortality than men, often due to underestimated risks and delayed diagnosis. This leads to less aggressive treatment and poorer outcomes for women with heart disease.
Area of Science:
- Cardiology
- Public Health
- Gender Studies
Background:
- Cardiovascular disease (CVD) is a leading global cause of death, with women experiencing higher mortality rates than men since 1984.
- Gender-specific differences in symptom presentation and underestimation of CVD risk in women contribute to delayed diagnosis and underuse of medical services.
- Misperceptions of female protection against heart disease lead to underestimation of risk, impacting healthcare-seeking behavior and treatment intensity.
Purpose of the Study:
- To review gender-specific differences in the epidemiology, diagnosis, and management of ischaemic heart disease (IHD).
- To highlight the impact of ageing and menopause on IHD in women.
- To address the underestimation of heart disease risk and its consequences in women.
Main Methods:
- Review of epidemiological data on cardiovascular disease mortality in men and women.
- Analysis of healthcare-seeking behavior and diagnostic timelines for men and women.
- Examination of treatment strategies and outcomes in relation to gender and age.
Main Results:
- Women experience greater mortality from cardiovascular disease compared to men.
- Delays in diagnosis and less intensive resource utilization are observed in women.
- Underestimation of risk and less aggressive treatment strategies contribute to poorer outcomes for women.
Conclusions:
- Gender-specific factors significantly influence cardiovascular disease outcomes.
- Addressing underestimation of risk and improving diagnostic and treatment timeliness for women is crucial.
- Ageing and menopause are critical factors in the management of ischaemic heart disease in women.
Abstract:
Cardiovascular disease is one of the leading causes of death worldwide. Since 1984, the total number of deaths from cardiovascular disease has been greater for women compared with men. This might be, in part, related to gender-specific differences in the presentation of people with chest pain but, importantly, the risk of heart disease in women is often underestimated owing to the misperception that women are 'protected' against cardiovascular disease. Studies have shown that medical services are underused, delays occur in health-care seeking behaviour, resource use patterns are less intensive, and it takes longer to diagnose women compared with men. This often leads to less aggressive treatment strategies which, in turn, may translate into poorer outcomes compared with those in men. In this chapter, we review the gender-specific differences in epidemiology, diagnosis, and management of people with ischaemic heart disease, and focus particularly on the effect of ageing and menopause in ischaemic heart disease.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Geriatric Patients
Coronary Artery Disease III: Clinical Manifestations
The Effect of Aging on Tissues

